Co-Authors
This is a "connection" page, showing publications co-authored by PEDRO TOMAS RAMIREZ and JAVIER LASALA.
Connection Strength
2.168
-
Rate of venous thromboembolism on an enhanced recovery program after gynecologic surgery. Am J Obstet Gynecol. 2023 08; 229(2):140.e1-140.e7.
Score: 0.227
-
Patient outcomes and adherence to an enhanced recovery pathway for open gynecologic surgery: a 6-year single-center experience. Int J Gynecol Cancer. 2022 Oct 06.
Score: 0.218
-
Impact of anesthesia technique on post-operative opioid use in open gynecologic surgery in an enhanced recovery after surgery pathway. Int J Gynecol Cancer. 2021 04; 31(4):569-574.
Score: 0.194
-
Effect of preoperative intravenous vs oral acetaminophen on postoperative opioid consumption in an enhanced recovery after surgery (ERAS) program in patients undergoing open gynecologic oncology surgery. Gynecol Oncol. 2021 02; 160(2):464-468.
Score: 0.192
-
A prospective randomized trial comparing liposomal bupivacaine vs standard bupivacaine wound infiltration in open gynecologic surgery on an enhanced recovery pathway. Am J Obstet Gynecol. 2021 01; 224(1):70.e1-70.e11.
Score: 0.187
-
Impact of compliance with an enhanced recovery after surgery pathway on patient outcomes in open gynecologic surgery. Int J Gynecol Cancer. 2019 11; 29(9):1417-1424.
Score: 0.177
-
Patient characteristics and opioid use prior to discharge after open gynecologic surgery in an enhanced recovery after surgery (ERAS) program. Gynecol Oncol. 2019 06; 153(3):604-609.
Score: 0.170
-
Comparison of patient reported symptom burden on an enhanced recovery after surgery (ERAS) care pathway in patients with ovarian cancer undergoing primary vs. interval tumor reductive surgery. Gynecol Oncol. 2019 03; 152(3):501-508.
Score: 0.170
-
Effect of an Enhanced Recovery After Surgery Program on Opioid Use and Patient-Reported Outcomes. Obstet Gynecol. 2018 08; 132(2):281-290.
Score: 0.163
-
Longitudinal perioperative patient-reported outcomes in open compared with minimally invasive hysterectomy. Am J Obstet Gynecol. 2024 02; 230(2):241.e1-241.e18.
Score: 0.058
-
Opioid-sparing anesthesia and patient-reported outcomes after open gynecologic surgery: a historical cohort study. Can J Anaesth. 2022 12; 69(12):1477-1492.
Score: 0.055
-
Incidence of acute kidney injury after open gynecologic surgery in an enhanced recovery after surgery pathway. Gynecol Oncol. 2021 10; 163(1):191-198.
Score: 0.050
-
Impact of a tiered discharge opioid algorithm on prescriptions and patient-reported outcomes after open gynecologic surgery. Int J Gynecol Cancer. 2021 07; 31(7):1052-1060.
Score: 0.050
-
Longitudinal patient-reported outcomes and restrictive opioid prescribing after minimally invasive gynecologic surgery. Int J Gynecol Cancer. 2021 01; 31(1):114-121.
Score: 0.048
-
Enhanced recovery for obese patients undergoing gynecologic cancer surgery. Int J Gynecol Cancer. 2020 10; 30(10):1595-1602.
Score: 0.047
-
Impact of implementation of an enhanced recovery program in gynecologic surgery on healthcare costs. Am J Obstet Gynecol. 2020 01; 222(1):66.e1-66.e9.
Score: 0.044
-
Guidelines for perioperative care in gynecologic/oncology: Enhanced Recovery After Surgery (ERAS) Society recommendations-2019 update. Int J Gynecol Cancer. 2019 05; 29(4):651-668.
Score: 0.043
-
Determining the Safety and Efficacy of Enhanced Recovery Protocols in Major Oncologic Surgery: An Institutional NSQIP Analysis. Ann Surg Oncol. 2019 Mar; 26(3):782-790.
Score: 0.042
-
A call for new standard of care in perioperative gynecologic oncology practice: Impact of enhanced recovery after surgery (ERAS) programs. Gynecol Oncol. 2016 05; 141(2):371-378.
Score: 0.035